Methyl Brevifolincarboxylate Attenuates Free Fatty Acid-Induced Lipid Metabolism and Inflammation in Hepatocytes through AMPK/NF-κB Signaling Pathway

Methyl Brevifolincarboxylate Attenuates Free Fatty Acid-Induced Lipid Metabolism and Inflammation in Hepatocytes through AMPK/NF-κB Signaling Pathway

The prevalence of non-alcoholic fatty liver disease (NAFLD) is one of the leading causes of chronic liver diseases worldwide. This study examined the potential protective effects of a naturally occurring polyphenolic compound, methyl brevifolincarboxylate (MBC) on fatty liver injury in vitro. The re...

Full description

Bibliographic Details
Main Authors: Madamanchi Geethangili, Chiao-Wei Lin, Harry J. Mersmann, Shih-Torng Ding
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:International Journal of Molecular Sciences
Subjects:
methyl brevifolincarboxylate
NAFLD
TG
de novo lipogenesis
lipid oxidation
inflammation
Online Access:https://www.mdpi.com/1422-0067/22/18/10062

Similar Items

Similar Items